Detalhe da pesquisa
1.
The link between interleukin-1ß and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study.
Ann Hematol
; 99(2): 359-361, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872359
2.
Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial.
Lancet Haematol
; 8(12): e902-e911, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34826413
3.
The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1ß in vascular endothelium in association with downregulation of miR-3p.
Leuk Res
; 58: 83-90, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28501737
4.
Identification of two novel mutations in adenine phosphoribosyltransferase gene in patients with 2,8-dihydroxyadenine urolithiasis.
Nucleosides Nucleotides Nucleic Acids
; 23(8-9): 1141-5, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15571218
5.
A 22-year-old woman with fulminant Chlamydia pneumoniae pneumonia.
Fukushima J Med Sci
; 48(1): 57-62, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12365599
6.
Serum Free Light Chain Only Myeloma with Cytoplasmic IgM.
Case Rep Hematol
; 2014: 676913, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25028614
7.
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib.
Biomark Res
; 2(1): 6, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24650752
8.
Independent Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Syndrome Clones in a Patient With Complete Bone Marrow Failure.
Hemasphere
; 2(5): e142, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30887006